CS199313B1 - Esters of thiophosphoric acid and process for preparing thereof - Google Patents
Esters of thiophosphoric acid and process for preparing thereof Download PDFInfo
- Publication number
- CS199313B1 CS199313B1 CS880478A CS880478A CS199313B1 CS 199313 B1 CS199313 B1 CS 199313B1 CS 880478 A CS880478 A CS 880478A CS 880478 A CS880478 A CS 880478A CS 199313 B1 CS199313 B1 CS 199313B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- oxo
- yield
- calculated
- oxy
- analysis
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Predemetom vynálezu sú nové 2-/5-alkoxy, alkyltio, chlór-l-alkyl, cyklohexyl, fenyl-6-oxo-lH-pyridazín-4-oxy/l,2,3-dioxafosfolan/fosforinan/-2-tiony a sposob ich přípravy. Nové zlúčeniny majú ovioídne účinky.The subject of the invention is the novel 2- (5-alkoxy, alkylthio, chloro-1-alkyl, cyclohexyl, phenyl-6-oxo-1H-pyridazin-4-oxy) 1,2,3-dioxaphospholan (phosphinanane) -2-thiones and method of their preparation. The novel compounds have ovioid effects.
Z literatúry sú známe příbuzné pyridazín-4-yl estery organofosforovýoh kyselin vzorcaRelated pyridazin-4-yl esters of organophosphoric acids of the formula are known in the literature
Rc R c
- R v ktorom R? znamená alkyl, alkoxy, Ν,Ν-dialkylamido, R2 znamená alkoxy, alkyltio, N-alkylamido, Ν,Ν-dialkylamido, R^ znamená halogén, alkoxy, alkyltio, íft znamená alkyl, cykloalkyl, fenyl a benzyl, X znamená kyslík, síru (čsl. pat. 133 599 a 141 95D·- R in which R? R 2 is alkyl, alkoxy, Ν, Ν-dialkylamido, R 2 is alkoxy, alkylthio, N-alkylamido, Ν, Ν-dialkylamido, R 6 is halogen, alkoxy, alkylthio, t is alkyl, cycloalkyl, phenyl and benzyl, X is oxygen , sulfur (art. no. 133 599 and 141 95D ·
Teraz sa zistili nové zlúčeniny všeobecného vzorca INew compounds of the formula I have now been found
199 313199 313
199 313 ir199 313 ir
v ktorom R^ znamená skupiny -CHg-CHg-, -CH/CH2/-CH//CH3/-, -CHg-CHg-CH/CH^/-» -CHg-C/CH^/g -CHg-, R2 znamená vodík, chlór, alkoxy, alkyltio, vždy s 1 až 3 atómami C v alkylskupinách, R^ znamená alkyl s 1 až 3 atómami C, cyklohexyl, fenyl.wherein R 1 is -CH 2 -CH 2 -, -CH 2 -CH 2 -CH 3 -CH 3 -, -CH 2 -CH 2 -CH (CH 2) -, -CH 2 -C (CH 2) -, g -CH 3 -, R 2 is hydrogen, chloro, alkoxy, alkylthio, in each case having 1 to 3 C atoms in the alkyl groups, R 1 is alkyl having 1 to 3 C atoms, cyclohexyl, phenyl.
Súčasne sa zistil sposob přípravy zlúčenin vzorca I reakciou 2-chlór-l,3,2-dioxafosfolan-2-tionu, resp. 2-chlór-l,3,2-dioxafosforinan-2-tionu vzorca IIAt the same time, a process for the preparation of the compounds of the formula I by reaction of 2-chloro-1,3,2-dioxaphospholane-2-thion, respectively, was determined. 2-chloro-1,3,2-dioxaphosphorinan-2-thione of formula II
R1 R 1
PP
Cl (II) v ktorom R^ má už uvedený výhnam s alkalickou eoíou l,5-disubstituovaného-6-oxo-lH-pyri-Cl (II) in which R1 has the above-mentioned advantage with an alkali salt of 1,5-disubstituted-6-oxo-1H-pyrrole;
organického rozpúfifadla, ako je acetonitril, dioxán, dimetylformamid, dimetylsulfoxid, metyletylketón, octan stylový, octan butylový, tetrahydrofurén pri tepiote 40 až 100 °C.an organic solvent such as acetonitrile, dioxane, dimethylformamide, dimethylsulfoxide, methyl ethyl ketone, stylish acetate, butyl acetate, tetrahydrofuran at a temperature of 40 to 100 ° C.
Nasledujúce příklady objasňujú, ale neobmedzujú nové zlúčeniny podía vynálezu a aposob ioh přípravy.The following examples illustrate, but do not limit, the novel compounds of the invention and methods of preparation.
Příklad 1Example 1
2-/5-met oxy-l-metyl-6-oxo-lH-pyridazín-4-oxy/-l,3»2-d ioxafosofolan-2-tion KO,O55 molu draselnéj soli 5-metoxy-l-metyl-6-oxo-lH-pyridazín-4-ólu v 100 ml acetonitril· sa přidalo 0,05 molu 2-chlór-l,3,2-dioxafosfolan-2-tionu. Reakčná zmes sa mieěala 2 hodiny pri refluxe. Po ukončení a ochladnutí sa za miešania vyliala do 500 ml vody. Vylúčená tuhá látka sa oddělila filtráciou, přečistila kryštalizáciou z toluénu. Získalo sa 11,3 g bielej kryštalickej látky s t.t. 66-67 °C, čo odpovědí 85%-nému výtažku zloženia: Analýza: Pre CgH^N^PS Vyp.: lljl3 % p 11,52 % S 10,07 % N (m.h.: 278,2) Zist.: 11,28 % P 11,81 % S 10,06 % N2- (5-Methoxy-1-methyl-6-oxo-1H-pyridazine-4-oxy) -1,3,2-dioxioxaphosopholane-2-thion KO, O55 mole of 5-methoxy-1-methyl potassium salt 6-oxo-1H-pyridazin-4-ol in 100 mL of acetonitrile was added 0.05 mol of 2-chloro-1,3,2-dioxaphospholane-2-thione. The reaction mixture was stirred at reflux for 2 hours. After completion and cooling, it was poured into 500 ml of water with stirring. The precipitated solid was collected by filtration and purified by crystallization from toluene. Yield: 11.3 g of white crystalline solid, mp 66-67 ° C, corresponding to 85% yield calculated composition: Calculated for N? CGH HP lljl3 Calc .: 11.52% P% N% S 10.07 (MW: 278.2) Found: 11.28% P 11.81% S 10.06% N
Štruktúra pripravenej látky bola dokázaná ifi a UV spektrami .The structure of the prepared substance was proved by ifi and UV spectra.
188 313 ΐδ namerané v CHCl-j.188 313 ΐδ measured in CHCl-j.
V(C-0) : 1032 cm1 H (C-0): 1032 cm @ -1
UV namerané v CH^OHsUV measured in CH 2 OH 3
Ά- max : 213 nm, 284 nm. ,Max max: 213 nm, 284 nm. .
Podobným postuporn boli připravené následovně látky.Substances were prepared in a similar manner.
Příklad 2Example 2
2-(l-fenyl - 5-metoxy-6-oxo-lH-pyridazín-4-oxy/-l,3,2-doxafoslan-2-tion t.t. = 168-170 °C (výřažok: 59,1 %)2- (1-phenyl-5-methoxy-6-oxo-1H-pyridazine-4-oxy) -1,3,2-doxaphoslan-2-thione mp = 168-170 ° C (yield: 59.1%)
Analýza: vypočítané: 9,10 % PAnalysis: calculated: 9.10% P
9,20 % P zistené:9.20% P found:
0,42 % S 9,81 % S0.42% S 9.81% S
8,25 % N 8,10 % N l6 v CHCI.: 'Ý (C=0) : 1650 om1, V (C=N) : 1628 cm1 8.25% N 8.10% N .: CHCl L6 in the Y (C = 0) 1650 OM 1, V (C = N) 1628 cm 1
UV v CH-jOH:UV in CH-jOH:
max : 213 nm, 288 nmmax: 213 nm, 288 nm
Příklad 3Example 3
2-/5-metoxy-l-metyl-6-oxo-lH-pyridazín-4-oxy/-4,5-dimetyl-l,3,2-dioxafosfolan-2-t ion n20 = 1,5421 (výíažok: 68,3)2- (5-methoxy-1-methyl-6-oxo-1H-pyridazine-4-oxy) -4,5-dimethyl-1,3,2-dioxaphospholan-2-one ion 20 = 1.5421 (yield) : 68.3)
DD
Analýza: vypočítané: 10,11 % P 10,77 % S 9,14 < N zistené: 10,23 % P 10,69 % S 9,44 % NAnalysis: calculated: 10.11% P 10.77% S 9.14 <N found: 10.23% P 10.69% S 9.44% N
Ιδ v CHC13: S1 (0=0) i 1645 om1, V(C=N) : 1 620 cm1 Ιδ in CHCl 3 : S 1 (0 = 0) i 1645 µm 1 , V (C = N): 1 620 cm 1
UV v CH30H:UV in CH 3 0H:
max : 213 nm, 286 nmmax: 213 nm, 286 nm
Přiklad 4 ‘Example 4 ‘
2-/l-fenyl-5-met oxy-6-oxo-lH-pyridazín-4-oxy/-4,5-dimetyl-l,3,2-dioxafoafolan-2-t ion2- (1-Phenyl-5-methoxy-6-oxo-1H-pyridazin-4-oxy) -4,5-dimethyl-1,3,2-dioxafoafolan-2-one
Příklad 5Example 5
2-/l-fenyl-5-chlór-6-oxo-lH-pyridazín-4-oxy/-4,5-dimetyl-l,3,2-dioxafosfolan-2-tion2- / l-phenyl-5-chloro-6-oxo-pyridazin-4-yloxy / -4,5-dimethyl-3,2-dioxaphospholane-2-thione
199 313 lí v CHC13 : y (0=0) : 1670 cm1, Ϋ (C=N) s 1612 cm1 v CC14 : V (C=0) : 1684 cm1, V(C=N) j 1613 cm1 199 313 li in CHCl 3 : y (0 = 0): 1670 cm 1 , Ϋ (C = N) with 1612 cm 1 in CC 1 4 : V (C = 0): 1684 cm 1 , V (C = N) j 1613 cm 1
UV v CH30H : % aax : 212 vm, 302 nmUV in CH 3 OH:% aax : 212 in m, 302 nm
Příklad 6Example 6
2-/5-metoxy-l-metyl-6-oxo-lH-pyridazín-4-oxy/-6-metyl-l,3,2-dioxafosforinan-2-tion2- / 5-methoxy-l-methyl-6-oxo-pyridazin-4-yloxy / 6-methyl-l, 3,2-dioxaphosphorinane-2-thione
Příklad 7Example 7
2-/5-chlór-l-mwtyl-6-oxo-lH-pyridazín-4-oxy/-6-metyl-l,3,2-ddioxafosforinan-2-tion t.t. = 78-80 °C (výíažok: 84,7 %)2- (5-chloro-1-methyl-6-oxo-1H-pyridazine-4-oxy) -6-methyl-1,3,2-dioxaphosphorinan-2-thion m.p. = 78-80 ° C (yield: 84.7%)
Analýza: vypočítané: 9,97 % P 10,32 % S 9,02 % N zistené: 10,06 % P 10,21 % S 9,20 % NAnalysis: calculated: 9.97% P 10.32% S 9.02% N found: 10.06% P 10.21% S 9.20% N
V (C=N) : 1599 cm'H (C = N): 1599 cm -1
213 nm, 296 nm213 nm, 296 nm
10,06 % P iC v CHC13: V /0=0/ : 1644 cm1,10.06% P iC in CHCl 3 : V / 0 = 0 /: 1644 cm 1 ,
UV v CH30H:UV in CH 3 0H:
maxmax
Příklad 8Example 8
2-/l-fenyl-5-metoxy-6-oxo-lH-pyridazín-4-oxy/-6-metyl-l,3,2-dioxafosforinan-2-tion t.t. = 74 - 76 °C (výíažok: 88,0 %)2- (1-phenyl-5-methoxy-6-oxo-1H-pyridazine-4-oxy) -6-methyl-1,3,2-dioxaphosphorinan-2-thione m.p. = 74-76 ° C (yield: 88.0%)
Příklad 9Example 9
2-/l-fenyl-5-chlór-6-oxo-lH-pyridazín-4-oxy/-6n>metyl-lf3,2-dioxafosforinan-2-tion t.t. = 136-138 °C (výtažok: 60,2 %)2- (1-phenyl-5-chloro-6-oxo-1H-pyridazine-4-oxy) -6-methyl-1,3,2-dioxaphosphorinan-2-thione m.p. = 136-138 ° C (yield: 60.2%)
Analýza: vypočítané: 8,31 % P 8,60 % S 7,52 % N zistené: 8,65 % P 8,81 % S 7,68 % NAnalysis: calculated: 8.31% P 8.60% S 7.52% N found: 8.65% P 8.81% S 7.68% N
Ifl v CHC13 : V (0=0) : 1761 cm1, V (C=N) : 1 613 cm1 v CC14 : (0=0) : 1685 cm1, V (c=N) : 1612 cm1 Ifl in CHCl 3 : V (0 = 0): 1761 cm 1 , V (C = N): 1613 cm 1 in CC 1 4 : (0 = 0): 1685 cm 1 , V (c = N): 1612 cm 1
UV v CH30H : %UV in CH 3 0H:%
212 nm, 309 nm max212 nm, 309 nm max
189 313189 313
Příklad 10Example 10
2-/l-i!ietyl-6-oxo-lH-pyridazín-4-oxy/-5,5-dimetyl-l, 3,2-dioxaf oaforinan-6-t ion t.t. = 114 - 115 °C (výfažok: 84,6 %)2- (1-diethyl-6-oxo-1H-pyridazine-4-oxy) -5,5-dimethyl-1,3,2-dioxaphthaforinan-6-one m.p. = 114 - 115 ° C (yield: 84.6%)
Analýza: vypočítané:Analysis: calculated:
zistené:found:
IČ v CHC13: V (0=0) :IR in CHC1 3: W (0 = 0):
UV v CH,0H: Λ _ :UV in CH, OH:
maxmax
10,67 % P 10,55 % P 1646 om10.67% P 10.55% P 1646 om
11,04 % S 9,65 % N% N, 11.04%
11,33 % S 9,51 % N11.33% N 9.51% N
Ϋ (C=N) : 1598 cm1 Ϋ (C = N): 1598 cm @ -1
211 nm, 292 nm211 nm, 292 nm
Příklad 11Example 11
2-/5-met oxy-l-metyl-6-oxo-lH-paridazín-4-oxy/-5,5-d imetyl-1,3,2-dioxafsforinan-2-tion2- (5-methoxy-1-methyl-6-oxo-1H-paridazine-4-oxy) -5,5-dimethyl-1,3,2-dioxaphosphorinan-2-thione
Příklad 12Example 12
2-/5-chlór-l-metyl-6-oxo-lH-pyridazin-4-oxy/-5,5-dimetyl-l,3,2-dioxafosforinan-2-tion t.t. = 160 - 162 °C (výíažok: 83,0 %}2- (5-chloro-1-methyl-6-oxo-1H-pyridazin-4-oxy) -5,5-dimethyl-1,3,2-dioxaphosphorinan-2-thione m.p. = 160-162 ° C (yield: 83.0%)
Analýza: vypočítané: 9,54 % P zistené: 9,52 %PAnalysis: Calculated: 9.54% P Found: 9.52% P
IČ v CHCI * v CC1.IR in CHCl * in CC1.
V (C=0) Ϋ (C = : 1652 cm”1,V (C = 0) Ϋ (C = 1652 cm ” 1 )
0) : 1678 cm“1,0): 1678 cm 1 ,
98,87 % S 10,02 % S Ϋ (C=N) V (C=N)98.87% S 10.02% S C (C = N) V (C = N)
8,63 % NN, 8.63
8,86 % NN, 8.86
1602 cm 1602 cm'1602 cm 1602 cm '
Příklad 13Example 13
2-/5-etoxy-l-metyl-6-oxo-lH-pyridazín-4-oxy/-5,5-dimetyl-l,3,2-dioxafoeforinan-2-tion t.t. =95-96 °C (výťažok: 84,2 %)2- (5-ethoxy-1-methyl-6-oxo-1H-pyridazine-4-oxy) -5,5-dimethyl-1,3,2-dioxaphoreforinan-2-thion m.p. = 95-96 ° C (yield: 84.2%)
Analýza: vypočítané: 9,26 % P 9,58 % S zistené: 9,16 % P 9,65 % SAnalysis: calculated: 9.26% P 9.58% S found: 9.16% P 9.65% S
IČ v CHC13 : Ý (C=0) : 1645 cm1, V (C=N) UV v CH3OH: A. nax : 215 nm, 286 nmIR in CHC1 3: Y (C = 0): 1645 cm 1, v (C = N) in the UV-CH 3 OH: A nax 215 nm, 286 nm
8,38 % N 8,64 % NN 8.38% N 8.64%
1615 cm1 1615 cm 1
Příklad 14Example 14
2-/5-etyltio-l-metyl-6-oxo-lH-pyridazín-4-oxy/-5,5-dimetyl-l,3,2-dioxafosforinan-2-tion t.t. = 109 - UÓ °C (výťažok: 76,8 %)2- (5-ethylthio-1-methyl-6-oxo-1H-pyridazine-4-oxy) -5,5-dimethyl-1,3,2-dioxaphosphorinan-2-thione m.p. = 109 - UO ° C (yield: 76.8%)
Analýza: vypočítané: 8,84 % P 18,30 % S 7,99 % NAnalysis: Calculated: 8.84% P 18.30% S 7.99% N
18,53 % S 7,93 % N18.53% N 7.93% N
V (C=N) : 1580 cm : 212 nm, 322 nm zistené:H (C = N): 1580 cm: 212 nm, 322 nm found:
IČ v CHCI,: y (C=0)IR in CHCl3: y (C = 0)
8,76 % P : 1636 cm1,8.76% P: 1636 cm 1 ,
UV v ch3oh maxUV in 3 ohm max
189 313 Příklad 15 ’189 313 Example 15 ’
2-/5vpřopyltio-metyl-6-oxo-lH-pyridazín-4-oxy/-5,5-dimetyl-l,3,2-dioxafoafořinan-2-tion t.t. « 116 - 117 °C (výtažok: 90,1 %)2- (5-propylthiomethyl-6-oxo-1H-pyridazine-4-oxy) -5,5-dimethyl-1,3,2-dioxaphoafraninan-2-thion m.p. «116 - 117 ° C (yield: 90.1%)
7,90 %N 8,06 % NN 7.90% 8.06% N
Příklad 16Example 16
2-/l-etyl-5-chlóř-6-oxo-lH-pyridazín-4-oxy/-5,5“dimetyl-l,3,2-dioxafosforinan-2-tion2- / l-ethyl-5-chloro-6-oxo-pyridazin-4-oxy / 5,5 'dimethyl-3,2-dioxaphosphorinane-2-thione
8,27 % N 8,47 % N cm8.27% N 8.47% N cm
Příklad 17Example 17
2-/l-cyklohexyl-5-metoxy-6-oxo-lH-pyridazín-4-oxy/-5,5-dimetyl«l,3,2-dioxafosforinan-2-tion2- / l-cyclohexyl-5-methoxy-6-oxo-pyridazin-4-yloxy / -5,5-dimethyl «l, 3,2-dioxaphosphorinane-2-thione
t.t. = 110 - 112 °C (výtažok: 69,8 %)mp = 110-112 ° C (yield: 69.8%)
Analýza: vypočítané: 7,97 % 7 8,25 % S 7,21 % N ziatené: 7,88 % P 8,34 % S 7,31 % NAnalysis: Calculated: 7.97% 7 8.25% S 7.21% N Sealed: 7.88% P 8.34% S 7.31% N
IC v CHCI, : Ϋ (C=0) : 1639 cm1, ý(C=N) : 1620 cm“1 IC in CHCI, Ϋ (C = 0): 1639 cm 1 , ý (C = N): 1620 cm -1
UV v CH-jOH:UV in CH-jOH:
maxmax
215 nm, 287 nm215 nm, 287 nm
Příklad 18Example 18
2-/l-fenyl-5-metoxy-6-oxo-lH-pyridazín-4-oxy/5,5-dimetyl-l,3,2-dioxafoBforinan-2-tion2- / l-phenyl-5-methoxy-6-oxo-pyridazin-4-oxy / 5,5-dimethyl-3,2-dioxafoBforinan-2-thione
t.t. = 150 - 151 Cmp = 150-151 C
IČ v CHC13 : UV v CH-jOH :IR in CHC1 3: CH-UV in Joh:
ziatené (výřažok: 90,2 %)glazed (yield: 90.2%)
: 216 nm, 296 nm max: 216 nm, 296 nm max
199 313199 313
PREDMET VYNÁLEZUOBJECT OF THE INVENTION
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS880478A CS199313B1 (en) | 1978-12-22 | 1978-12-22 | Esters of thiophosphoric acid and process for preparing thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS880478A CS199313B1 (en) | 1978-12-22 | 1978-12-22 | Esters of thiophosphoric acid and process for preparing thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CS199313B1 true CS199313B1 (en) | 1980-07-31 |
Family
ID=5439105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS880478A CS199313B1 (en) | 1978-12-22 | 1978-12-22 | Esters of thiophosphoric acid and process for preparing thereof |
Country Status (1)
Country | Link |
---|---|
CS (1) | CS199313B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8466096B2 (en) | 2007-04-26 | 2013-06-18 | Afton Chemical Corporation | 1,3,2-dioxaphosphorinane, 2-sulfide derivatives for use as anti-wear additives in lubricant compositions |
-
1978
- 1978-12-22 CS CS880478A patent/CS199313B1/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8466096B2 (en) | 2007-04-26 | 2013-06-18 | Afton Chemical Corporation | 1,3,2-dioxaphosphorinane, 2-sulfide derivatives for use as anti-wear additives in lubricant compositions |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2378261C2 (en) | Method of preparing salt compound (4,5-dihydroisoxazol-3-yl)thiocarboxamidine | |
EP0462639A1 (en) | Preparation of 2-chloropyridine derivatives | |
DE69616240T2 (en) | 1,2-dioxetane derivatives as active substances in chemiluminescence | |
PL108914B1 (en) | Method of producing new derivatives of uracil | |
US5981786A (en) | Process for producing (meth)acrylate derivatives | |
CS199313B1 (en) | Esters of thiophosphoric acid and process for preparing thereof | |
US4195021A (en) | 1,3-Disubstituted 2-azetidinone antibitotics | |
US4355172A (en) | Process for 4-(D-3-amino-3-carboxypropoxy)-phenylglyoxylic acid oxime derivatives | |
EP0620228A1 (en) | Novel reactive thiophosphate derivatives of thia(dia)zole acetic acid and process for preparing the same | |
US4440682A (en) | Stereospecific synthesis of isocephalosporins and 2-oxa isocephalosporins | |
SU955861A3 (en) | Process for producing derivatives of streptovaricin | |
US4305891A (en) | Method for preparing O-4-(hydroxyalkyl)-thiophenyl phosphates | |
RU2027704C1 (en) | Method of synthesis of 6-fluoro-1,2-benzisothiazole, ortho-substituted phenacyl-derivative, and a method of its synthesis | |
US4230871A (en) | Process for preparing 5,6-dihydro-2-methyl-1,4-oxathiin derivatives | |
US4175076A (en) | Azetidinone mercury sulfides and process therefor | |
CA1184178A (en) | Optically-active diamide derivatives | |
FI71562C (en) | FOERFARANDE FOER FRAMSTAELLNING AV 6- - SUBSTITUERADE PENICILLANSYRADERIVAT OCH SAOSOM MELLANPRODUKTER ANVAENDBARA 6-PERFLUORALKYLSULFONYLOXIPENICILLANSYRADERIVAT. | |
US4216333A (en) | Process for preparing N-tritylimidazole compounds | |
US4918188A (en) | Oxadiazines | |
US4542215A (en) | Method for preparing 8-acylthio-1,2,3,4,5,6-hexahydro-2,6-methano-3,6(e),11(a)-trimethyl-3-benzazocines | |
CS217685B1 (en) | New o-/2-chlorethyl/-o-isobutyl-o-/1-methyl-5-metoxy-6-oxo 1h-pyridazin-4-yl/thiopheosphate and method of making the same | |
US4226767A (en) | Intermediates for 3-aminoazetidin-2-ones | |
SU1017703A1 (en) | Process for preparing 3-methyl-5-oxo-2,2-bis(1,1.3-trihydroperfluoro-propoxy)-4-cyane-4-ethoxy carbonyl-1,2-azaphosphol-1-ene | |
PL172005B1 (en) | Aryl hydroxyimidazolinylpropionamides | |
KR810001979B1 (en) | Process for preparing 2,5-dihydro-1,2-thiazino(5,6-b)indol-3-carboxamides-1,1-dioxides |